您要查找的是不是:
- Methods:Twenty-five patients with advanced ovarian carcinoma were treated with CTX+DDP by continous hyperthermic peritoneal perfusion(CHPP). 方法:以环磷酰胺静脉化疗联合顺铂腹腔热灌注治疗25例中晚期卵巢癌,观察其疗效及其副反应。
- The nature killer (NK)activity and the subset of lymphocytes isolated from peripheral blood(PBL),ascitic fluid (EAL)and fresh tumor tissue(TIL)were studied on 31 cases of advanced ovarian carcinoma(AOC),using MTT,ID-IF methods. 本文运用噻唑蓝比色法。 间接免疫荧光法测定了31引例晚期卵巢癌患者的外周血淋巴细胞(PBL)、腹水淋巴细胞(EAL)及肿瘤浸润淋巴细胞(TIL)的NK活性和细胞亚群,并对常规手术、化疗对肿瘤患者免疫功能的影响进行初步探讨。
- Clinical and Experimental Study on the Mechanism of Immune Escape and the Treatment of CIK Cells for Advanced Ovarian Carcinoma with Multidrug Resistance 晚期卵巢癌多药耐药的免疫逃逸机制以及CIK细胞实验性治疗的基础与临床研究
- advanced ovarian carcinoma 晚期卵巢癌
- ATX mRNA was also detected in ovarian carcinoma tissues. ATX mRNA在卵巢癌细胞亦可见明显扩增条带。
- The cytoreductive surgery is the standard surgery for ovarian carcinoma. 卵巢癌肿瘤细胞减灭术是目前晚期卵巢上皮癌的标准术式。
- Despite improvements in progression-free survival and overall survival, the problems of relapsing and drug-resisting are still serious and long-term survival rates for patients with advanced epithelial ovarian carcinoma(EOC) remain disappointing. 患者无疾病进展生存时间及总生存时间得以改善,但复发和耐药问题依然严重,长期生存率并未提高。 最近,寻找一种与PTX、铂类均无交叉耐药且疗效确切的药物与之配伍治疗晚期卵巢癌成为热门研究课题。
- Methods 154 cases of advanced epithelial ovarian carcinoma treated in our hospital were analyzed retrospectively.The effect of cytoreductive surgery and chemotherapy for ovarian cancer was studied. 方法回顾性分析154例晚期上皮性卵巢癌患者的临床资料,就手术和化疗对预后的影响进行评价。
- A.Cytoreductive surgery improves response to chemotherapy and survival of women with advanced ovarian cancer. 外科细胞减数治疗可以提高进展期卵巢癌妇女的化疗效果和存活率。
- Ovarian carcinoma is one of the most common and lethal gynecological malignancy, and the knowledge about its nature has always been concerned. 摘要卵巢癌是最常见的妇科恶性肿瘤之一,如何正确认识这类肿瘤一直备受关注。
- Objective To study the apoptosis of ovarian carcinoma cell strain COC1 induced by arsenic trioxide (As_2O_3). 目的研究三氧化二砷(As2O3)诱导卵巢癌细胞株COC1凋亡的作用机理。
- Methylation of TMS1/ASC gene in promotor region is related with the genesis of ovarian carcinoma. TMS1/ASC基因启动子甲基化与卵巢癌发生的关系
- Conclusion:Nonlethal dosage ultrasound could lead mitochondria damage to ovarian carcinoma by cells cavitation. 结论:非致死剂量超声可能通过空化效应而致卵巢癌细胞线粒体损伤。
- The standard treatment of advanced ovarian cancer includes primary cytoreductive(debulking) surgery followed by chemotherapy aiming at optimal residual tumor volumes. 目前卵巢癌的标准治疗方案是以手术为主,辅以术后化疗,实现满意肿瘤细胞减灭术是手术的目的。
- Longtime and low dose HRT has no significant risk of endometrial carcinoma, ovarian carcinoma and mammary carcinoma. 小剂量HRT对发生子宫内膜癌、卵巢癌和乳腺癌的危险性无明显影响;
- Conclusion:DDP with cisplatin by CHPP on patients with late ovarian carcinoma may be a safe and effective therapy. 结论:化疗联合顺铂腹腔热灌注治疗对中晚期卵巢癌疗效较好,毒副反应较少。
- Objective To investigate the expressions and significance of P21 and P27 proteins in ovarian carcinoma. 摘要目的探讨P21和P27蛋白在卵巢癌组织中的表达及其意义。
- Methods 26 courses of postoperative systemic CBDCA therapy were carried out in 7 patients with ovarian carcinoma. 方法选择术后接受卡铂联合化疗方案的卵巢癌患者7例,共观察26个疗程。
- Conclusion: Nonlethal dosage ultrasound could lead mitochondria damage to ovarian carcinoma by cells cavitation. 结论 :非致死剂量超声可能通过空化效应而致卵巢癌细胞线粒体损伤。
- Twenty-eight patients with advanced ovarian cancer were treated with cisplatin+carboplatin+etoposide by continuous hyperthermic peritoneal perfusion(CHPP)and high frequency diathermy. 以顺铂+卡铂+依托泊甙为主的联合方案行腹腔持续热灌注化疗并腹腔射频透热治疗28例晚期卵巢上皮癌,观察其疗效及毒副反应。